Effect of central administration of ondansetron, a 5-hydroxytryptamine-3 receptor antagonist on gastric and duodenal ulcers

Fundamental and Clinical Pharmacology

Volumn 23, Issue 3, 2009, Pages 303-309

  Ramesh, Salvi Tushar ^a   Asad, Mohammed ^a   Dhamanigi, Sunil Samson ^a   Prasad, V Satya ^b  

^a KRUPANIDHI COLLEGE OF PHARMACY   (India)

^b MNR Medical College   (India)

Author keywords

Cysteamine duodenal ulcer; gastric cytoprotection; gastric secretion; ondansetron; rat; ulcer healing

Indexed keywords

ACETIC ACID; ALCOHOL; MERCAPTAMINE; ONDANSETRON; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CELL PROTECTION; COLD STRESS; CONTROLLED STUDY; DISEASE MODEL; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DUODENUM ULCER; IMMOBILIZATION STRESS; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PYLORUS LIGATION; RAT; RECEPTOR BLOCKING; STOMACH ACID SECRETION; STOMACH MUCUS; STOMACH PROTECTION; STOMACH SECRETION; STOMACH ULCER; ULCER HEALING;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DUODENAL ULCER; GASTRIC ACID; GASTRIC MUCOSA; INJECTIONS, INTRAVENTRICULAR; MALE; ONDANSETRON; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN, 5-HT3; SEROTONIN ANTAGONISTS; STOMACH ULCER;

EID: 67149113356     PISSN: 07673981     EISSN: 14728206     Source Type: Journal    
DOI: 10.1111/j.1472-8206.2009.00668.x     Document Type: Article

References (50)

1. Parmar N.S., Jagruthi K.D. A review of the current methodology for the evaluation of gastric and duodenal anti ulcer agents. Indian J. Pharmacol. (1993) 25 120 135.
2. Ohta Y., Kobayashi T., Ishiguro I. Role of endogenous serotonin and histamine in the pathogenesis of gastric mucosal lesions in unanaesthetised rats with a single treatment of compound 48/80, a mast cell degranulator. Pharmacol. Res. (1999) 39 261 267. (Pubitemid 29182324)
3. 3 receptor antagonist in thyrotropin releasing hormone-induced gastric lesions. Peptides (1997) 18 893 898. (Pubitemid 27400220)
4. 3 receptors in the anti-ulcer effect of calcitonin. Gen. Pharmacol. (1994) 25 1599 1605.
5. Ogle C.W., Hui S.C. The influence of peripheral or central administration of ondansetron on stress-induced gastric ulceration in rats. Experientia (1995) 51 786 789.
6. Motilva V., Lopez A., Martin M.J., La Casa C., Alarcon de la Lastra C. Cytoprotective activity of cisapride on experimental gastric mucosal lesions induced by ethanol. Role of endogenous prostaglandins. Prostaglandins (1996) 52 63 74. (Pubitemid 26299825)
7. Taniyama K., Nakayama S., Takeda K. et al. Cisapride stimulates motility of intestine via the 5-hydroxytryptamine receptors. J. Pharmacol. Exp. Ther. (1991) 258 1098 1104.
8. 4 receptors? Eur. J. Pharmacol. (1992) 212 51 59.
9. 1D receptors. Int. J. Exp. Pathol. (1995) 76 237 240.
10. Sanders-Bush E., Mayer S.E. 5-hyrdoxytryptamine (serotonin): receptor agonist and antagonist, in : Hardman J.G., Limbard L.E. (Eds Goodman and Gilman's the pharmacological basis of therapeutics. 10th edn, McGraw Hill, New York, USA. 2001, p. 274.
11. Schubert M.L. Gastric secretion. Curr. Opin. Gastroenterol. (2003) 19 519 525. (Pubitemid 37330469)
12. Petersson M., Hulting A.L., Andersson R., Uvnäs-Moberg K. Long term changes in gastric cholecystokinin and insulin in response to oxytocin treatment. Neuroendocrinol (1999) 69 202 208. (Pubitemid 29134495)
13. Vogel H.G. Drug discovery and evaluation, 2nd edn, Springer-Verlag, Heidelberg, Berlin. 2002, p. 1379.
14. Asad M., Shewade D.G., Koumaravelou K., Abraham B.K., Vasu S., Ramaswamy S. Gastric anti-secretary and ant-ulcer activity of oxytocin in rats and guinea pigs. Life Sci (2001) 70 17 24. (Pubitemid 33124353)
15. 3 and cholinergic mechanisms in improgan antinociception. Pharmacol. Biochem. Behav. (2005) 80 505 510. (Pubitemid 40299352)
16. Teruya H., Yamazato M., Muratani H. et al. Role of ouabain-like compound in the rostral ventrolateral medulla in rats. J. Clin. Invest. (1997) 99 2791 2798. (Pubitemid 27259827)
17. Ganguly A.K. A method for quantitative assement of experimentally produced ulcers in stomach of rats. Experientia (1969) 25 1124.
18. Shay H., Komarov S.A., Fele S.S., Meranze D., Gruenstein H., Siplet H. A simple method for uniform production of gastric ulceration in rat. Gastroenterology (1945) 5 43 61.
19. Kulkarni S.K. Handbook of experimental pharmacology, 3rd edn, Vallabh Prakashan, New Delhi, India. 1999, pp. 148-150.
20. Asad M., Rajesh K.S., Ahmad M. Effect of administration of saline or glucose during fasting on the development of gastric ulcers in pylorus ligated rats. Ethiop. Pharm. J. (2003) 16 1 6.
21. Hawk P.B., Oser B.L., Summerson H.W. Practical physiological chemistry, 12th edn, Churchill, London, UK. 1947, p. 347.
22. Debnath P.K., Gode K.O., Govinda D.D., Sanyal A.K. Effect of propranolol on gastric secretion in rats. Br. J. Pharmacol. (1974) 51 213 216.
23. Lowry C.H., Roseborough N.I., Farr A.L., Randall R.J. Protein measurement with folin phenol reagent. J. Biol. Chem. (1951) 193 265 275.
24. Prabha T., Babu M.D., Priyambada S., Agrawal V.K., Goel R.K. Evaluation of Pongamia Pinnata root extract on gastric and mucosal offensive and defensive factors in rats. Indian J. Exp. Biol. (2003) 41 304 310. (Pubitemid 36405512)
25. Brzozowski T., Konturek P.C.h., Konturek S.J. et al. Involvement of endogenous cholecystokinin and somatostatin in gastroprotection induced by intra duodenal fat. J. Clin. Gastroenterol. (1998) 27 125 137.
26. Vincent G.P., Galvin G.B., Rutkowski J.L., Pare W. Body orientation, food deprivation and potentiation of restraint induced gastric lesions. Gastroenterol. Clin. Biol. (1977) 1 539 34.
27. Szabo S. Animal model for human disease: duodenal ulcer disease. Amer. J. Pathol. (1978) 73 273 276.
28. Desai J.K., Goyal R.K., Parmar N.S. Characterization of dopamine receptor subtypes involved in experimentally induced gastric and duodenal ulcers in rats. J. Pharm. Pharmacol. (1999) 51 187 192. (Pubitemid 29131312)
29. Okabe S., Roth J.L.A., Pfeiffer C.J. Differential healing periods of acetic acid ulcer model in rats and cats. Experientia (1971) 27 146 148.
30. Soll A.H. Pathogenesis of peptic ulcer and implication for therapy. New. Engl. J. Med. (1990) 322 909 916. (Pubitemid 20108381)
31. Surendra S. Evaluation of gastric anti-ulcer activity of fixed oil of tulsi and possible mechanism. Indian J. Exp. Biol. (1999) 36 253 257.
32. Feinle C., Read N.W. Ondansetron reduces nausea induced by gastroduodenal stimulation without changing gastric motility. Am. J. Physiol. (1996) 271 (4 Pt 1) 591 597.
33. Simpson K.H., Murphy P., Colthup P.V., Whelan P. Concentration of ondansetron in cerebrospinal fluid following oral dosing in volunteers. Psychopharmacology (Berl) (1992) 109 497 498.
34. Michael N.P., Charles T.R. Stressful life events, acid hypersecretion and ulcer disease. Gastroenterology (1983) 84 114 119.
35. Brodie D.A.Q., Hanson H.M. A study of the factors involved in the production of gastric ulcer by the restraint technique. Gastroenterology (1960) 38 353 360.
36. Ogle C.W., Hui S.C., Qiu B.S., Li K.M. 5-Hydroxytryptamine3-receptor blockade protects against gastric mucosal damage in rats. Acta Physiol. Hung. (1992) 80 181 188. (Pubitemid 24126526)
37. Szabo S., Horner H.C., Maull H., Schnoor J., Chiueh C.C., Palkovits M. Biochemical changes in tissue catecholamines and serotonin in duodenal ulceration caused by cysteamine propionitrile in the rat. J. Pharmacol. Exp. Ther. (1987) 240 871 878. (Pubitemid 17043587)
38. 3 receptor as a therapeutic target. Expert Opin. Ther. Targets. (2007) 11 527 540. (Pubitemid 46487600)
39. Miyake A., Mochizuki S., Takemoto Y., Akuzawa S. Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol. Pharmacol. (1995) 48 407 416.
40. 3A receptors in cells of the immune system. Scand. J. Rheumatol. (2004) 33 (Suppl. 119) 9 11. (Pubitemid 39180179)
41. 3-AS receptor subunit in the rat central nervous system. Eur. J. Neurosci. (2002) 15 449 457. (Pubitemid 35463663)
42. 3 receptor mRNA. Proc. Natl Acad. Sci. USA (1993) 90 1430 1434.
43. 3 receptors in the rat spinal cord: immunohistochemistry and in situ hybridization. Neuroreport (1995) 6 257 261.
44. Steward L.J., West K.E., Kilpatrick G.J., Barnes N.M. Labelling of 5-HT3 receptor recognition sites in the rat brain using the agonist radioligand [3H]meta-chlorophenylbiguanide. Eur. J. Pharmacol. (1993) 243 13 18. (Pubitemid 23300536)
45. Yoneda M., Tache Y. Vagal regulation of gastric prostaglandin E2 release by central TRH in rats. Am. J. Physiol. Gastrointest. Liver Physiol. (1993) 264 G231 G236. (Pubitemid 23069583)
46. Tanaka T., Guth P., Tache Y. Role of nitric oxide in gastric hyperemia induced by central vagal stimulation. Am. J. Physiol. Gastrointest. Liver Physiol. (1993) 264 G280 G284. (Pubitemid 23069589)
47. Taché Y., Yoneda M., Kato K., Király A., Sütö G., Kaneko H. Intracisternal thyrotropin-releasing hormone-induced vagally mediated gastric protection against ethanol lesions: central and peripheral mechanisms. J. Gastroenterol. Hepatol. (2008) 9 S29 S35.
48. Naylor R.J., Rudd J.A. Pharmacology of ondansetron. Eur. J. Anaesthesiol. Suppl. (1992) 6 3 10.
49. 3 receptors in gastric function and ethanol-induced mucosal damage in rat stomachs. Pharmacology (1994) 49 137 143. (Pubitemid 24236155)
50. 2 receptors in rats. Am. J. Physiol. (1995) 269 (1 Pt 2) 1 6.